Merit Financial Group »

Immunitybio shares owned by Merit Financial Group

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $401k 44k 9.15
2023-12-31 $220k 44k 5.02
2023-09-30 $74k 44k 1.69
2023-06-30 $66k 24k 2.78
2023-03-31 $43k 24k 1.82

More positions owned by Merit Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Vlu (IUSV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Portfli Intrmdit (SPTI)
Ishares Tr Core Msci Eafe (IEFA)
United Parcel Service CL B (UPS)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Usd Inv Grde Etf (USIG)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard World Mega Grwth Ind (MGK)

View all positions for Merit Financial Group

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio